Unlock regulatory insights with Watson. Learn More
Return to Docket

Determine whether Sulfamethoxazole, Trimethoprim, and Phenazopyride HCI, have been voluntarily withdrawn or withheld for safety or efficacy reasons

Abstract: DocketStatus: OPEN
Type: Non-Rule Making
Docket Item Code P
Center CDER


Click here to view all comments of this document.